NPS Pharmaceuticals, Inc.
PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism
(Thu, Jul 24)
NPS Pharmaceuticals: The Small Bio-Tech You Should Not Be Ignoring With 30% Upside
at Seeking Alpha
(Mon, Jul 21)
Despite Selloff, Traders Remain Positive on AbbVie Deal
(Tue, Jul 8)